ACUTE THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 07 Apr 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86830651
- Registration number
- 5048286
- Mark type
- Design + words
- Filed
- 24 Nov 2015
- Published for opposition
- 12 Jul 2016
- Registered
- 27 Sept 2016
- Attorney of record
- James Klobucar
Goods and services
- Class 042 — Scientific and technological services: research and development in the field of pharmaceuticals featuring acute therapeutic agents
Owner
- Ascendia Pharmaceuticals, LLC, Monmouth Junction, NJ, US
- Ascendia Pharmaceuticals, LLC, Monmouth Junction, NJ, US
- Ascendia Pharmaceuticals, LLC, Monmouth Junction, NJ, US
Prosecution history
- 07 Apr 2023 — CANCELLED SEC. 8 (6-YR)
- 27 Sept 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Sept 2016 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2016 — PUBLISHED FOR OPPOSITION
- 22 Jun 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 31 May 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 May 2016 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 25 May 2016 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 24 May 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2016 — USE AMENDMENT ACCEPTED
- 24 May 2016 — AMENDMENT TO USE PROCESSING COMPLETE
- 24 May 2016 — USE AMENDMENT FILED
- 23 May 2016 — TEAS AMENDMENT OF USE RECEIVED